Company / Accounts Receivable
PAVmed Inc. Accounts Receivable History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$18.0K
FY2024
5-year range
$17.0K / $200.0K
FY2021-FY2024
Trend
-70.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $17,000 to $18,000 over the past 2 years.
Based on SEC 10-K filings.
$18,000 in FY2024 with a 3-year CAGR of -55.2%.
Improved from $17,000 to $18,000 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -55.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -55.2%, indicating a declining trend.
- In FY2024, accounts receivable decreased 70.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $18.0K | -70.5% |
| FY2023 | $61.0K | +258.8% |
| FY2022 | $17.0K | -91.5% |
| FY2021 | $200.0K | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026